Reply to: Platelet Aggregation, Platelet Serotonin and Pancreatitis

Konstantinos Mimidis*
8, Chrisostomou Smirnis str. GR-68 100 Alexandroupolis Greece
Corresponding Author:
Konstantinos Mimidis
8, Chrisostomou Smirnis str.
GR-68 100 Alexandroupolis
Tel: +30-2551.074.090
Fax: +30-2551.030.324
E-mail: [email protected]
Received: June 1st, 2004
Visit for more related articles at JOP. Journal of the Pancreas




Platelet Adhesiveness; Platelet Aggregation


p-5HT: platelet-serotonin; SSRIs: selective serotonin-reuptake inhibitors


Dear Sir:
In response to the letter of Drs. Lechin and van der Dijs [1], we would like to express our gratitude concerning the additional information presented by the author. Indeed, the crucial role of platelet-serotonin (p-5HT) has been well-established in thrombogenesis and the release of serotonin has been proposed as the “gold standard” assay for the detection of thrombocyte activation [2].
However, the purpose of our study was to test a newly developed method of evaluating primary hemostasis based on the platelet function analyzer (PFA-100TM) in a prethrombotic model such as acute pancreatitis. This method had only been applied to hemorrhagic diathesis and its usefulness in thrombosis was unknown [3, 4, 5, 6]. Thus, we focused on testing the specific method rather than commenting on the underlying pathophysiology of platelets in acute pancreatitis.
In conclusion, the authors’ statements regarding the p-5HT levels and the potent use of selective serotonin-reuptake inhibitors (SSRIs) in acute pancreatitis serve as a valuable proposal for future studies.
Konstantinos Mimidis
Vassilios Papadopoulos


1. Lechin F, van der Dijs B. Platelet aggregation, platelet serotonin and pancreatitis. JOP. J Pancreas (Online) 2004; 5(4):237-238.
2. Gobbi G, Mirandola P, Tazzari PL, Ricci F, Caimi L, Cacchioli A, et al. Flow cytometry detection of serotonin content and release in resting and activated platelets. Br J Haematol 2003; 121:892-6. [PMID 12786800]
3. Wuillemin WA, Gasser KM, Zeerleder SS, Lämmle B. Evaluation of a Platelet Function Analyser (PFA-100®) in patients with a bleeding tendency. Swiss Med Wkly 2002; 132:443-8. [PMID 12457302]
4. Gosselin RC, Paglieroni T, Owings J, Utter G, Jacoby R, Larkin EC. Decreased PFA-100 values is associated with increased platelet activation. In: 7th Annual Meeting of the European Hematology Association. Florence, Italy, 6-9 June 2002. Bologna, Italy: Monduzzi Editore, International Proceedings Division, 2002. [ISBN. Book: 88-323-2606-X - CDROM: 88-323-2607-9]
5. Mammen EF, Comp PC, Gosselin R, Greenberg C, Hoots WK, Kessler CM, et al. PFA-100 system: a new method for assessment of platelet dysfunction. Semin Thromb Hemost 1998; 24:195-202. [PMID 9579642]
6. Escolar G, Cases A, Vinas M, Pino M, Calls J, Cirera I, et al. Evaluation of acquired platelet dysfunctions in uremic and cirrhotic patients using the platelet function analyzer (PFA-100TM): influence of hematocrit elevation. Haematologica 1999; 84:614-9. [PMID 10406903]
Select your language of interest to view the total content in your interested language

Viewing options

Post your comment

Share This Article

Flyer image

Post your comment

captcha   Reload  Can't read the image? click here to refresh